Correction: A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model

Ananda Mookerjee ¹, Michele Graciotti ², Lana E. Kandalaft ^1,2^*

¹ Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, USA
² Ludwig Cancer Research Center, University of Lausanne, Lausanne, Switzerland; Department of Oncology, University Hospital of Lausanne, Lausanne, Switzerland

*Corresponding Author: *Corresponding author: Lana E. Kandalaft, Email: , Email: lana.kandalaft@chuv.ch

Abstract

This corrects the article "A cancer vaccine with dendritic cells differentiated with GM-CSF and IFNα and pulsed with a squaric acid treated cell lysate improves T cell priming and tumor growth control in a mouse model" published on 2018: Volume 08, Issue 03, Pages 211-221. Correction to: BioImpacts 10.15171/bi.2018.24, published on 2018: Volume 08, Issue 03 The original version of this article contained a typographical error in the spelling of the author Lana E. Kandalaft, which was incorrectly given as Lana Kandalaft. This has now been corrected in the PDF and HTML versions of the article.

First Name

Last Name

Email Address

Comments

Security code

Generate New Image

Type the code from the image

Abstract View: 1782

years	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec
2024	22	9	31	17
2023	17	17	9	14	12	12	14	16	16	11	22	18
2022	13	19	19	22	12	18	23	22	18	11	18	12
2021	21	14	22	13	17	21	27	15	6	15	17	19
2020	17	17	33	24	30	30	43	216	125	48	46	28
2019	20	51	121	35	43	44	19	42	12	20	26	21